*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : VO1225000
CHEMICAL NAME : Salicylic acid, 4-amino-
CAS REGISTRY NUMBER : 65-49-6
BEILSTEIN REFERENCE NO. : 0473071
REFERENCE : 4-14-00-01967 (Beilstein Handbook Reference)
LAST UPDATED : 199701
DATA ITEMS CITED : 11
MOLECULAR FORMULA : C7-H7-N-O3
MOLECULAR WEIGHT : 153.15
WISWESSER LINE NOTATION : ZR CQ DVQ
COMPOUND DESCRIPTOR : Drug
Mutagen
Primary Irritant
SYNONYMS/TRADE NAMES :
* 4-Amino-2-hydroxybenzoic acid
* Aminopar
* Aminosalicylic acid
* p-Aminosalicylic acid
* 4-Aminosalicylic acid
* Aminox
* Apacil
* APAS
* Benzoic acid, 4-amino-2-hydroxy-
* Deapasil
* Entepas
* Gabbropas
* Hellipidyl
* 2-Hydroxy-4-aminobenzoic acid
* 3-Hydroxy-4-carboxyaniline
* Kyselina p-aminosalicylova
* NSC 2083
* Osacyl
* Pamacyl
* Pamisyl
* Para-amino salicylic acid
* Paramycin
* Para-Pas
* Parasal
* Parasalicil
* Parasalindon
* Pas
* Pasa
* Pasalon
* Pasara
* PAS-C
* Pascorbic
* Pasem
* Pask
* Pasmed
* Pasnodia
* Pasolac
* Propasa
* Rezipas
* Sanipriol-4
*** HEALTH HAZARD DATA ***
** SKIN/EYE IRRITATION DATA **
TYPE OF TEST : Standard Draize test
ROUTE OF EXPOSURE : Administration into the eye
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 100 mg/24H
REACTION SEVERITY : Moderate
REFERENCE :
85JCAE "Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J.,
Prague, Czechoslovakia, Avicenum, 1986 Volume(issue)/page/year: -,659,1986
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPPMAB Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great
Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949-
Volume(issue)/page/year: 2,764,1950
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 4250 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ZENBAX Zeitschrift fuer Naturforschung, Teil B: Anorganische Chemie,
Organische Chemie, Biochemie, Biophysik, Biologie. (Tuebingen, Fed. Rep.
Ger.) V.2B-27B, 1947-1972. For publisher information, see ZNCBDA.
Volume(issue)/page/year: 6B,183,1951
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPPMAB Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great
Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949-
Volume(issue)/page/year: 2,764,1950
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 3898 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ANTBAL Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher
information, see AMBIEH. Volume(issue)/page/year: 18,249,1973
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 3650 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FEPRA7 Federation Proceedings, Federation of American Societies for
Experimental Biology. (Bethesda, MD) V.1-46, 1942-87.
Volume(issue)/page/year: 10,289,1951
** MUTATION DATA **
TYPE OF TEST : Cytogenetic analysis
ROUTE OF EXPOSURE : Oral
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 50 mg/kg
REFERENCE :
NULSAK Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in
Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta
700 019, India) V.1- 1958- Volume(issue)/page/year: 22,96,1979
TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Rodent - mouse Mammary gland
DOSE/DURATION : 2 mmol/L/24H (Continuous)
REFERENCE :
JTSCDR Journal of Toxicological Sciences. (Japanese Soc. of Toxicological
Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku,
Tokyo 113, Japan) V.1- 1976- Volume(issue)/page/year: 5,141,1980
*** REVIEWS ***
TOXICOLOGY REVIEW
AJMEAZ American Journal of Medicine. (Technical Pub., 875 Third Ave., New
York, NY 10022) V.1- 1946- Volume(issue)/page/year: 38,409,1965
*** STATUS IN U.S. ***
EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9
EPA TSCA Section 8(b) CHEMICAL INVENTORY
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Salicylanilide, 3'-chloro-5-nitro-
| 6505-75-5 |
Salicylanilide, 4'-chloro-3-nitro-
| 6490-99-9 |
Ruta graveolens L., rootSUBSTANCE DEFINITION :From the Mediterranean region, cultivated in India and belonging to thefamily RutaceaeREFERENCE :JOETD7 Journal of Ethnopharmacology. (Elsevier Scientific Pub. IrelandLtd., POB 85, Limerick, Ireland) V.1- 1979- Volume(issue)/page/year:34,49,1991
| 6490-99-9 |
Salicylanilide, 4'-chloro-5-nitro-
| 6490-98-8 |
Salicylanilide, 2'-chloro-3-nitro-5'-trifluoromethyl-
| 33713-13-2 |
Salicylanilide, 4',5-dibromo-
| 87-12-7 |
Salicylanilide, 3,4'-dibromo-5-chlorothio-, acetate(ester)
| 23233-88-7 |
Salicylanilide, 4',5-dichloro-
| 1147-98-4 |
Salicylanilide, 2',5-dichloro-4'-nitro-
| 50-65-7 |
Salicylanilide, 3',4'-dichloro-3-nitro-
| 29378-25-4 |
Salicylanilide, 2',5-dichloro-4'-nitro-, compd. with2-aminoethanol (1:1)
| 1420-04-8 |
Salicylanilide, 3,4'-dinitro-
| 39832-34-3 |
Salicylanilide, 4'-fluoro-3-nitro-
| 4043-45-2 |
Rufomycin A
| 37248-35-4 |
Rutamycin
| 1404-59-7 |
Salicylanilide, 4'-hydroxy-
| 526-18-1 |
Salicylanilide, 4'-iodo-3-nitro-
| 10515-48-7 |
Salicylanilide, 3,3',4',5-tetrachloro-
| 1154-59-2 |
Salicylanilide, tribromo-
| 1322-38-9 |
Salicylanilide, 3,4',5-tribromo-
| 87-10-5 |
Salicylanilide, 3,4',5-tribromo- mixed with3,5-dibromosalicylanilide
| 8015-34-7 |
Salicylanilide, 3,4',5'-triiodo-
| 14437-45-7 |
Salicylic acid
| 69-72-7 |
Salicylic acid, 4-acetamido-
| 50-86-2 |
Salicylic acid, 4-acetamido-, acetate (ester)
| 50-86-2 |
Ruthenate(2+), nitrosylpentachloro-, diammonium,(OC-6-21)-
| 13820-58-1 |
Salicylic acid, 4-acetamido-, compd. with7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline (2:1)
| 58-77-5 |
Salicylic acid, 5-acetamido-, compd. withhexamethylenetetramine
| 58-77-5 |
Salicylic acid, acetate
| 50-78-2 |
Salicylic acid, acetate, anhydride
| 1466-82-6 |
Salicylic acid, acetate, calcium salt
| 69-46-5 |
Salicylic acid, acetate, ester with4'-hydroxyacetanilide
| 5003-48-5 |
Salicylic acid, acetate, ester with methanediol
| 5003-48-5 |
Salicylic acid, acetate mixed with ethylalpha-(p-chlorophenoxy)isobutyrate (1:1)
| 5003-48-5 |
Salicylic acid, acetate, magnesium salt
| 132-49-0 |
Salicylic acid, acetate, 7-nitro-8-quinolyl ester
| 29007-29-2 |
Ruthenate(2+), nitrosylpentachloro-, dipotassiumhydrate
| 14854-54-7 |
Salicylic acid, acetate, sodium salt
| 493-53-8 |
Salicylic acid, acetyl-, and7-methoxy-alpha,10-dimethylphenothiazine-2-aceticacid
| 72360-92-0 |
Salicylic acid, 3-allyl-, methyl ester
| 31456-98-1 |
Salicylic acid, 4-amino-
| 65-49-6 |
Salicylic acid, 5-amino-
| 89-57-6 |
Salicylic acid, 4-amino-, acetate
| 102338-89-6 |
Salicylic acid, 4-amino-, acetate, sodium salt
| 102338-90-9 |
Salicylic acid, (o-aminobenzoyl)hydrazide
| 28864-31-5 |
Salicylic acid, (p-aminobenzoyl)-, methyl ester,hydrochloride
| 28864-31-5 |
Salicylic acid, amino-, sec-butyl ester
| 102338-91-0 |
Ruthenium(3+), (adenosine)pentaammine-, tribromide
| 67848-03-7 |
Salicylic acid, p-amino-, calcium salt (21)
| 133-15-3 |
Salicylic acid, amino-, 2-chloroethyl ester
| 16987-14-7 |
|
|